About David Colaizzi
David Colaizzi is a board chairman at Myris Therapeutics.
David Colaizzi first appears on SEC filings in 2022.
Experience
This experience comes from David Colaizzi's profile and from SEC filings. For roles taken from filings, the years are when the filings name David Colaizzi in the role, so the role may have started earlier or lasted longer.
BS
BioHybrid Solutions Current
Chair of the Board
2021 – Present
SI
SignatureDx Current
Co-Founder, CEO
2020 – Present
MM
Maitri Medicinals Current
Board Member, Investor
2019 – Present
Myris Therapeutics, Inc.
Board Chairman
2022 – 2026 · Sharpsburg, PA
Develops antibody-linked medicines for people with cancer.
FI
fivestar*
Chair of the Board
1997 – 2022
GE
Genelex
Principal, CTO
2018 – 2020
JI
JAM, Inc
Development Director
1994 – 1996
Key Colleagues at Startups
The people David Colaizzi works with at each company, as listed on that company's latest Form D.
Myris Therapeutics, Inc. · Form D, Oct 14, 2026
Laura Benjamin
CEO, Board Director
RW
Rebecca Wolfe
Executive officer
AS
Antonina Simakova
Executive officer
Alan Russell
Promoter
BF
Barbara Fox
Board Director
Krzysztof Matyjaszewski
Co-Founder and Board Director
Mark Murcko
Board Director